A. Starace

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial

S. Durgam, I. Laszlovszky, Dayong Li, 2014, Schizophrenia Research.

The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study.

G. Sachs, T. Ketter, S. Durgam, 2018, Journal of affective disorders.

Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.

G. Sachs, S. Durgam, I. Laszlovszky, 2015, Journal of affective disorders.

Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.

J. Calabrese, P. Keck, S. Durgam, 2015, The Journal of clinical psychiatry.

The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial

S. Durgam, I. Laszlovszky, Dayong Li, 2011, Bipolar disorders.

P.2.e.016 Cariprazine in the treatment of acute mania in bipolar disorder: a double-blind, placebo-controlled, phase III trial

I. Laszlovszky, G. Németh, J. Goodman, 2012, European Neuropsychopharmacology.

P.2.d.026 Efficacy and safety of low- and high-dose cariprazine in patients with acute mania associated with bipolar I disorder

J. Calabrese, S. Durgam, I. Laszlovszky, 2013, European Neuropsychopharmacology.